138 related articles for article (PubMed ID: 2293909)
1. HLA class I and II antigens in South African blacks with Graves' disease.
Omar MA; Hammond MG; Desai RK; Motala AA; Aboo N; Seedat MA
Clin Immunol Immunopathol; 1990 Jan; 54(1):98-102. PubMed ID: 2293909
[TBL] [Abstract][Full Text] [Related]
2. Correlation of HLA types and clinical findings in Japanese patients with hyperthyroid Graves' disease: evidence indicating the existence of four subpopulations.
Inoue D; Sato K; Enomoto T; Sugawa H; Maeda M; Inoko H; Tsuji K; Mori T; Imura H
Clin Endocrinol (Oxf); 1992 Jan; 36(1):75-82. PubMed ID: 1559302
[TBL] [Abstract][Full Text] [Related]
3. HLA-A, B, C and DR antigens in young South African blacks with Type 1 (insulin-dependent) diabetes mellitus.
Omar MA; Hammond MG; Asmal AC
Diabetologia; 1984 Jan; 26(1):20-3. PubMed ID: 6584368
[TBL] [Abstract][Full Text] [Related]
4. HLA immunogenetic heterogeneity in black American patients with Graves' disease.
Sridama V; Hara Y; Fauchet R; DeGroot LJ
Arch Intern Med; 1987 Feb; 147(2):229-31. PubMed ID: 3468887
[TBL] [Abstract][Full Text] [Related]
5. HLA-DR associations with Graves' disease in eastern Hungary.
Stenszky V; Kozma L; Balazs C; Farid NR
Clin Invest Med; 1983; 6(3):181-4. PubMed ID: 6580983
[TBL] [Abstract][Full Text] [Related]
6. Human lymphocyte antigens in Graves' disease: correlation with persistent course of disease.
Baldini M; Pappalettera M; Lecchi L; Orsatti A; Meroni L; Tozzi R; Scalamogna M; Cantalamessa L
Am J Med Sci; 1995 Jan; 309(1):43-8. PubMed ID: 7825652
[TBL] [Abstract][Full Text] [Related]
7. Association of HLA antigens with thyrotoxic Graves' disease and periodic paralysis in Hong Kong Chinese.
Hawkins BR; Ma JT; Lam KS; Wang CC; Yeung RT
Clin Endocrinol (Oxf); 1985 Sep; 23(3):245-52. PubMed ID: 3865750
[TBL] [Abstract][Full Text] [Related]
8. HLA-DQ3 is associated with Graves' disease in African-Americans.
Ofosu MH; Dunston G; Henry L; Ware D; Cheatham W; Brembridge A; Brown C; Alarif L
Immunol Invest; 1996; 25(1-2):103-10. PubMed ID: 8675226
[TBL] [Abstract][Full Text] [Related]
9. Genetic differences shown by HLA typing among Japanese patients with euthyroid Graves' ophthalmopathy, Graves' disease and Hashimoto's thyroiditis: genetic characteristics of euthyroid Graves' ophthalmopathy.
Inoue D; Sato K; Maeda M; Inoko H; Tsuji K; Mori T; Imura H
Clin Endocrinol (Oxf); 1991 Jan; 34(1):57-62. PubMed ID: 2004473
[TBL] [Abstract][Full Text] [Related]
10. HLA and Graves' disease: an association with HLA-DRw3.
Allannic H; Fauchet R; Lorcy Y; Heim J; Gueguen M; Leguerrier AM; Genetet B
J Clin Endocrinol Metab; 1980 Oct; 51(4):863-7. PubMed ID: 6932402
[TBL] [Abstract][Full Text] [Related]
11. HLA-DR3 and HLA-DR5 associated thyrotoxicosis--two different types of toxic diffuse goiter.
Schleusener H; Schernthaner G; Mayr WR; Kotulla P; Bogner U; Finke R; Meinhold H; Koppenhagen K; Wenzel KW
J Clin Endocrinol Metab; 1983 Apr; 56(4):781-5. PubMed ID: 6131902
[TBL] [Abstract][Full Text] [Related]
12. Association of HLA-DR tissue types with Graves' disease in Taiwan.
Tsai KS; Hsieh RP; Chang CC; Chen FW; Lee SC
Taiwan Yi Xue Hui Za Zhi; 1989 Apr; 88(4):336-41. PubMed ID: 2794934
[TBL] [Abstract][Full Text] [Related]
13. Failure to demonstrate cell-mediated immune responses to thyroid antigens in Graves' disease using in vitro assays of lymphokine-mediated migration inhibition.
Ludgate ME; Ratanachaiyavong S; Weetman AP; Hall R; McGregor AM
J Clin Endocrinol Metab; 1985 Jan; 60(1):98-102. PubMed ID: 3871093
[TBL] [Abstract][Full Text] [Related]
14. HLA antigens and Graves' disease in Black South Africans.
Kalk WJ; Maier G; van Drimellen M; Levin J; Reinach SG
Tissue Antigens; 1983 Jul; 22(1):7-15. PubMed ID: 6604348
[No Abstract] [Full Text] [Related]
15. Genetic factors in Graves' ophthalmopathy.
Frecker M; Stenszky V; Balazs C; Kozma L; Kraszits E; Farid NR
Clin Endocrinol (Oxf); 1986 Nov; 25(5):479-85. PubMed ID: 3113776
[TBL] [Abstract][Full Text] [Related]
16. HLA-A, -B, -C and -DR antigens in patients with Graves' disease and their correlation with signs and clinical course.
Dahlberg PA; Holmlund G; Karlsson FA; Säfwenberg J
Acta Endocrinol (Copenh); 1981 May; 97(1):42-7. PubMed ID: 6164233
[TBL] [Abstract][Full Text] [Related]
17. Japanese Graves' disease: association with HLA-Bw46.
Naito S; Sasaki H; Arakawa K
Endocrinol Jpn; 1987 Oct; 34(5):685-8. PubMed ID: 3436299
[TBL] [Abstract][Full Text] [Related]
18. Human lymphocyte antigens (HLA) and Graves' disease in Turkey.
Orhan Y; Azezli A; Carin M; Aral F; Sencer E; Molvalilar S
J Clin Immunol; 1993 Sep; 13(5):339-43. PubMed ID: 7902362
[TBL] [Abstract][Full Text] [Related]
19. Association of HLA antigen BW35 with severe Graves' ophthalmopathy.
Sergott RC; Felberg NT; Savino PJ; Blizzard JJ; Schatz NJ; Sanford CA
Invest Ophthalmol Vis Sci; 1983 Jan; 24(1):124-7. PubMed ID: 6600737
[TBL] [Abstract][Full Text] [Related]
20. HLA immunogenetic heterogeneity within patients with Graves' disease.
Davies TF
Arch Intern Med; 1987 Oct; 147(10):1845. PubMed ID: 3499128
[No Abstract] [Full Text] [Related]
[Next] [New Search]
